##gff-version 3
##sequence-region Q69383 1 105
Q69383	UniProtKB	Chain	1	105	.	.	.	ID=PRO_0000186775;Note=Endogenous retrovirus group K member 6 Rec protein	
Q69383	UniProtKB	Motif	13	20	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q69383	UniProtKB	Motif	50	59	.	.	.	Note=Nuclear export signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q69383	UniProtKB	Compositional bias	13	20	.	.	.	Note=Poly-Arg	
Q69383	UniProtKB	Mutagenesis	4	6	.	.	.	Note=No loss of function. SEM->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	13	15	.	.	.	Note=Total loss of function and dominant negative effect. RRR->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Total loss of function and dominant negative effect%3B when associated with A-14%3B A-16%3B A-18 and A-20. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10936083;Dbxref=PMID:10936083	
Q69383	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Total loss of function and dominant negative effect%3B when associated with A-13%3B A-16%3B A-18 and A-20. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10936083;Dbxref=PMID:10936083	
Q69383	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Total loss of function and dominant negative effect%3B when associated with A-13%3B A-14%3B A-18 and A-20. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10936083;Dbxref=PMID:10936083	
Q69383	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Total loss of function and dominant negative effect%3B when associated with A-13%3B A-14%3B A-16 and A-20. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10936083;Dbxref=PMID:10936083	
Q69383	UniProtKB	Mutagenesis	19	20	.	.	.	Note=No loss of function. NR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Total loss of function and dominant negative effect%3B when associated with A-13%3B A-14%3B A-16 and A-18. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10936083;Dbxref=PMID:10936083	
Q69383	UniProtKB	Mutagenesis	30	32	.	.	.	Note=Total loss of function and dominant negative effect. MVT->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	37	39	.	.	.	Note=Total loss of function and dominant negative effect. MKL->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	42	44	.	.	.	Note=Total loss of function and dominant negative effect. TKK->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	48	50	.	.	.	Note=Total loss of function and dominant negative effect. PTW->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	53	55	.	.	.	Note=Total loss of function and dominant negative effect. LKK->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Exclusive nuclear localization%3B when associated with A-56 and A-59. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10683442;Dbxref=PMID:10683442	
Q69383	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Exclusive nuclear localization%3B when associated with A-53 and A-59. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10683442;Dbxref=PMID:10683442	
Q69383	UniProtKB	Mutagenesis	59	61	.	.	.	Note=Partial loss of function. LAT->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Exclusive nuclear localization%3B when associated with A-53 and A-56. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10683442;Dbxref=PMID:10683442	
Q69383	UniProtKB	Mutagenesis	66	68	.	.	.	Note=Total loss of function and dominant negative effect. NTK->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	76	78	.	.	.	Note=Total loss of function and dominant negative effect. MLL->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	82	84	.	.	.	Note=Total loss of function and dominant negative effect. MIV->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	86	88	.	.	.	Note=Partial loss of function. MVS->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
Q69383	UniProtKB	Mutagenesis	93	95	.	.	.	Note=No loss of function. NSS->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11000203;Dbxref=PMID:11000203	
